SHENZHEN, China, 23 June 2022 – MGI, a world-leading life science innovator, has been awarded a Silver Globee® in the 14th Annual 2022 Golden Bridge Business and Innovation Awards® for its innovative COVID-19 pandemic control and response efforts worldwide.
Since the rise of COVID-19, MGI has actively supported pandemic prevention and control in over 70 countries and regions, including South Africa, Serbia, Saudi Arabia, the United Arab Emirates, Canada, and Australia.
From enabling large-scale nucleic acid testing with MGI automation systems to sequencing virus genomes for tracing and understanding variants, MGI’s DNBSEQ™ sequencers, automation systems, and proprietary ATOPlex technology have been continuously applied to combat COVID-19 and protect communities.
“MGI is honored to be recognized for our innovative technology and inclusive approach towards tackling the pandemic by the Globee® Awards,” said Duncan Yu, President at MGI. “Through advanced genetic science and technology, we are proud to support countries on the frontline, enhancing testing capability and informing pandemic response efforts.”
The Golden Bridge Awards® are a premier global business awards program, judged by over 100 experts, recognising achievements across industries. Fellow winners include IBM, KPMG, and Honeywell.
Amidst the ongoing fight against COVID-19, MGI remains committed to detecting, monitoring, and tracing COVID-19 and its variants. The company continues to improve the efficiency, flexibility, and mobility of its core tools and technology to meet growing testing demands and reach more people in need.
